Citigroup, Inc. (C) has sold off a part of its Diners Club credit card processing business to Elavon, a subsidiary of US Bancorp (USB), as it continues to rid itself of unwanted assets. Elavon acquired Citibank's Diners Club Card merchant-location portfolio in Western Europe, which represents more than 75,000 merchants. Small and mid-size businesses that accept Diners Club cards in the region will now process their transactions through Elavon. Terms of the deal were not disclosed. Separately, Elavon has also signed an agreement with Diners Club International, a unit of Discover Financial Services (DFS). The agreement will enable Elavon to provide processing, funding and customer support services for merchants that accept Diners Club International cards in the U.K., Ireland, France, Switzerland and Germany. Citigroup, once the largest U.S. bank by assets, fell behind last year after a series of acquisitions by rivals. The ...

las Vegas CRWENewswire.com is pleased to announce a stock highlight on Continucare Corporation, Elavon, Iowa Health System Sign up to receive FREE Stock-PR alerts from CRWENewswire.com at http://www.crwenewswire.com/?tag=stock-pr

Continucare Corporation (NYSE Amex:CNU) announced today August 13, 2009that it has expanded its service offerings through the acquisition of Professional Sleep Diagnostics, Inc., a full service operator of sleep diagnostic centers. The most common sleep disorder, obstructive sleep apnea or OSA, is a serious health condition that afflicts more than 18 million adults in the United States.

Elavon, a wholly owned subsidiary of US Bancorp (NYSE: USB) and a leading global card acquirer, announced today August 13, 2009 they signed a three-year agreement with FNC Inc., a technology company offering tailored solutions for the real-estate and mortgage industry to streamline industry processes, regulations and compliance.

Iowa Health System (IHS), the largest integrated healthcare provider in the state, announced today August 13, 2009 the adopted

...

PennyOmega.com Stock Report!

PennyOmega.com Hot Stock News & Alerts!

 

Thursday August 13, 2009

PennyOmega.com Stock Report!

**************************************************************

Ceragenix Pharmaceuticals, Inc. (OTCBB:CGXP), a medical device company focused on infectious disease and dermatology, today provided an update on its previously disclosed, ongoing long-term preclinical testing of a silicone medical device incorporating the Company’s CeraShield(TM) antimicrobial technology. The prototype device being tested was an intravaginal silicone ring. Antimicrobial intravaginal rings may be of potential benefit in preventing transmission of certain sexually transmitted diseases. After 224 days of continuous antimicrobial efficacy, the coated ring lost its efficacy in preventing colonization and the test was ended.

Deer Consumer Products, Inc. (Nasdaq: DEER; Website: www.deerinc.com), one of the world’s largest manufacturers of

...